Kanada - angličtina - Health Canada

sandoz canada incorporated - pomalidomide - capsule - 4mg - pomalidomide 4mg

Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

celgene sdn. bhd. - pomalidomide -

Saudská Arábia - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

celgene europe ltd - pomalidomide - capsule - 3 mg

Saudská Arábia - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

celgene europe b.v, netherlands - pomalidomide - capsule - 3 mg

Saudská Arábia - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bristol-myers squibb / pharma eeig, ireland - pomalidomide - capsule - 3 mg

Saudská Arábia - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bristol-myers squibb / pharma eeig, ireland - pomalidomide - capsule - 3 mg

Japonsko - angličtina - すりの適正使用協議会 RAD-AR Council, Japan

bristol-myers squibb - pomalidomide - capsule with dark blue opaque cap imprinted with “poml” and green opaque body imprinted with “3mg”, major axis: 19.4 mm, minor axis: 6.9 mm

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - pomalidomide 1mg;   - capsule - 1 mg - active: pomalidomide 1mg   excipient: gelatin indigo carmine iron oxide yellow mannitol pregelatinised maize starch sodium stearyl fumarate titanium dioxide - pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - pomalidomide 2mg;   - capsule - 2 mg - active: pomalidomide 2mg   excipient: erythrosine gelatin indigo carmine iron oxide yellow mannitol pregelatinised maize starch sodium stearyl fumarate titanium dioxide - pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - pomalidomide 4mg;   - capsule - 4 mg - active: pomalidomide 4mg   excipient: brilliant blue fcf gelatin indigo carmine mannitol pregelatinised maize starch sodium stearyl fumarate titanium dioxide - pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy